sleep apnoea
Research Roundup
Debbie Rigby rounds up the latest research news Is semaglutide cost-effective at closing the gap for Aboriginal and Torres Strait Islander Australians with cardiovascular disease and obesity without type 2 …
The push for MedTech tariff exemptions
Listed sleep apnoea mask-maker Resmed says it’s reprieved from US President Trump’s tariffs for now and its CEO will push for all MedTech to be exempt in his other role …
Excessive daytime sleepiness
By understanding the underlying causes of excessive daytime sleepiness (EDS), its presentation and the management options available, pharmacists can provide the most appropriate counselling and advice. By Jala Moushi, BPharm(Hons), …
To sleep perchance to stop breathing: sleep apnoea
Obstructive sleep apnoea (OSA) is a condition that pharmacists will commonly encounter; given the current level of under-diagnoses, there is a key role for pharmacists in recognising symptoms and facilitating …
Aussies in the dark about poor sleep
Most Australians suffer broken sleep – and 62% are ignoring “critical” signs that poor sleep could signify a serious problem, says Amcal The 2019 Sleep Health Survey, conducted by Amcal, …
Sleep service a success
Amcal and Guardian pharmacies have hailed the first six months of their national sleep apnoea program a success The announcement follows a significant lift in program uptake and specialist referrals. …
Health Check: is snoring anything to worry about?
There’s nothing quite like the sound of snoring as the ultimate sleep interrupter, writes Jason Amatoury Jason Amatoury, Postdoctoral Research Fellow, Biomedical Engineer, Upper Airway Physiologist, Neuroscience Research Australia There’s nothing …